Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion

Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion
July 4, 2012 | BigPharma | Editor
Pharmaceutical drug maker GlaxoSmithKline PLC will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, misbranding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes